DZ Bank’s Wave Life Sciences WVE Stock Holding History

DZ Bank’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-18,017	Closed	-$722K	–	1097
2018 Q1	$722K	Buy	+18,017	New	+$757K	﹤0.01%	726

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DZ Bank's WVE Position: Q2 2018 in Review

DZ Bank sold out of Wave Life Sciences (WVE) in Q2 2018, closing a stake of 18,017 shares — an estimated $722K sold.

DZ Bank first reported a position in WVE in Q1 2018 and held it in 1 quarter. The position peaked at $722K in Q1 2018. 78 funds tracked by Wall St. Rank hold WVE as of Q2 2018.

DZ Bank reported no remaining Wave Life Sciences position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 18,017 Wave Life Sciences shares in Q2 2018, an estimated $722K.
DZ Bank first reported a position in Wave Life Sciences in Q1 2018 and held it in 1 quarter.
DZ Bank's Wave Life Sciences position peaked at $722K in Q1 2018.
78 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.